Literature DB >> 16170283

Risk factors, prevention and treatment of hypertension in pregnancy.

R A Smith1, P N Baker.   

Abstract

Hypertensive diseases in pregnancy are common and are associated with significant maternal and perinatal mortality and morbidity. Risk factors for pre-eclampsia include socio-demographical factors (extremes of reproductive age, socio-economic status, ethnic group), genetic factors, pregnancy factors (multiple pregnancies, primigravidae, previous pre-eclampsia) or personal medical history (obesity, chronic renal disease, chronic hypertension, diabetes mellitus, thrombophilia). These risk factors and Doppler screening can help target interventions such as aspirin and calcium that have been proven to reduce the incidence of pre-eclampsia in high risk women. Expectant management is the mainstay of treatment for pre-eclampsia. Hypertension should be controlled by oral or intravenous antihypertensive agents as necessary. Magnesium sulphate is the agent of choice for both the treatment and prevention of eclampsia. Fluid balance and thromboprophylaxis are also both important elements in the management of severe pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170283

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  2 in total

1.  The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.

Authors:  Lucinda Govender; Irene Mackraj; Prem Gathiram; Jack Moodley
Journal:  Cardiovasc J Afr       Date:  2012-04       Impact factor: 1.167

2.  Long Noncoding RNA 00473 Is Involved in Preeclampsia by LSD1 Binding-Regulated TFPI2 Transcription in Trophoblast Cells.

Authors:  Dan Wu; Yetao Xu; Yanfen Zou; Qing Zuo; Shiyun Huang; Sailan Wang; Xiyi Lu; Xuezhi He; Jing Wang; Tianjun Wang; Lizhou Sun
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-06       Impact factor: 8.886

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.